Literature DB >> 19745372

Data-mining-based detection of adverse drug events.

Emmanuel Chazard1, Cristian Preda, Béatrice Merlin, Grégoire Ficheur, Régis Beuscart.   

Abstract

Every year adverse drug events (ADEs) are known to be responsible for 98,000 deaths in the USA. Classical methods rely on report statements, expert knowledge, and staff operated record review. One of our objectives, in the PSIP project framework, is to use data mining (e.g., decision trees) to electronically identify situations leading to risk of ADEs. 10,500 hospitalization records from Denmark and France were used. 500 rules were automatically obtained, which are currently being validated by experts. A decision support system to prevent ADEs is then to be developed. The article examines a decision tree and the rules in the field of vitamin K antagonists.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19745372

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  4 in total

1.  Interoperability of medical databases: construction of mapping between hospitals laboratory results assisted by automated comparison of their distributions.

Authors:  Grégoire Ficheur; Emmanuel Chazard; Aurélien Schaffar; Matthieu Genty; Régis Beuscart
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

2.  Constructing Clinical Decision Support Systems for Adverse Drug Event Prevention: A Knowledge-based Approach.

Authors:  Vassilis Koutkias; Vassilis Kilintzis; George Stalidis; Katerina Lazou; Chrysa Collyda; Emmanuel Chazard; Peter McNair; Regis Beuscart; Nicos Maglaveras
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

Review 3.  Towards Personalized Antithrombotic Treatments: Focus on P2Y12 Inhibitors and Direct Oral Anticoagulants.

Authors:  Jean Terrier; Youssef Daali; Pierre Fontana; Chantal Csajka; Jean-Luc Reny
Journal:  Clin Pharmacokinet       Date:  2019-12       Impact factor: 6.447

4.  Detecting Diseases in Medical Prescriptions Using Data Mining Tools and Combining Techniques.

Authors:  Mehdi Teimouri; Farshad Farzadfar; Mahsa Soudi Alamdari; Amir Hashemi-Meshkini; Parisa Adibi Alamdari; Ehsan Rezaei-Darzi; Mehdi Varmaghani; Aysan Zeynalabedini
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.